Matches 1 - 50 out of 337 1 2 3 4 5 6 7 >


Match Document Document Title
8912356 DCC mediated coupling for halofenate manufacture  
The present application discloses a process for the preparation of a halofenate compound of the formula (III) or a salt thereof: wherein R, X and X′ are as defined herein, the process comprising...
8846292 Radiation-sensitive composition  
A radiation-sensitive composition containing a resist compound having a high sensitivity, a high resolution, a high etching resistance, and a low outgas which forms a resist pattern with good...
8614347 Fluorous dendrimers and methods for production thereof  
The present invention concerns the design of an environmentally friendly and efficient fluorous phase based on dendritic architectures containing short semifluorinated groups on their periphery.
8592622 Polymerizable fluorine-containing compound  
A polymerizable fluorine-containing compound represented by formula (1), wherein R1 represents a polymerizable double-bond containing group, R2 represents an acid-labile protecting group, R3...
8541614 Process for the preparation of (−)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester  
The present invention is directed to a novel process for the preparation of (4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester, useful in the treatment of...
8203019 Crystalline solid and amorphous forms of (−)- halofenate and methods related thereto  
The present invention provides crystalline solid and amorphous forms of (−)-halofenate. The crystalline solid forms may be used in various pharmaceutical compositions, and are particularly...
8101095 Antiferroelectric orthoconic liquid crystalline material with long pitch and the method of its preparation  
The racemic and chiral compounds expressed by common formula 1 and formula 2: wherein the lateral substituents X1, X2, X3, X4, X5, X6, X7 and X8 in the benzene rings represent independently...
7737176 Substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them  
The invention relates to compounds of the formula I: and to the pharmaceutically acceptable salts thereof, to processes for the preparation of them and to pharmaceutical compositions comprising...
7718656 Prostaglandin derivatives  
Nitroderivatives of prostaglandin amides having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
7618690 Polymerizable liquid crystal compound, liquid crystal composition, optical anisotropic material and optical element  
A liquid crystal compound represented by the formula CH2═CR1—COO-(L)k-E1-E2-E3-E4-R2 wherein R1: a hydrogen atom or a methyl group; R2: a C1-8 alkyl group; k: 0 or 1; L: —(CH2)pO— or —(CH2)q—...
7597942 Polymerisable liquid crystal material  
The invention relates to a polymerisable liquid crystal (LC) material, to optically biaxial films prepared thereof, to novel polymerisable compounds used therein and to the use of the material and...
7569518 Pyridazine Compound and Use Thereof  
A pyridazine compound represented by formula (1): has an excellent plant disease controlling effect.
7465752 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof  
Compounds of the formula (I): in which R, R1, R2 and R3 are as defined in the description, to their use for the treatment of dyslipidaemia, atherosclerosis and diabetes, to pharmaceutical...
7432394 Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines  
The present invention provides a methods and compounds for producing an enantiomerically enriched α-(phenoxy)phenylacetic acid compound of the formula: from a mixture of its enantiomers, where R1...
7199259 Resolution of α-(phenoxy)phenylacetic acid derivatives  
The present invention provides a method for producing an enantiomerically enriched α-(phenoxy)phenylacetic acid compound of the formula (I): from its enantiomeric mixture, where R1 is alkyl or...
7070838 Liquid crystalline compound, liquid crystal composition and their polymers  
The present invention provides a compound represented by formula (1) defined in the specification and a liquid crystal composition comprising the compound. The invention further provides a polymer...
6897333 Process for the preparation of fibrates  
A process for the preparation of fibrates of formula I in which R1 is a halogen atom, a 2,2-dichloro-cyclopropyl group, a (4-chlorophenyul)-hydroxymethyl group, a-4-chlorobenzoyl group or a...
6869967 Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives  
Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these...
6770775 Method of synthesizing optically enriched α-halo-esters, and product and composition therefrom  
A method of synthesizing highly optically enriched α-halo-esters comprises reacting acid halides with a cinchona alkaloid catalyst and a base to form intermediate ketenes. The ketenes are reacted...
6759101 Liquid crystalline materials containing perfluoroalkyl and alkenyl tail groups  
Compounds that are useful as components in liquid crystal compositions, particularly in ferroelectric liquid crystal compositions. Compounds of the invention are rod-like molecules with a...
RE37947 Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof  
Novel pharmaceutically/cosmetically-active aromatic polyenic compounds have the structural formula (I): and are useful for the treatment of a wide variety of disease states, whether human or...
6337306 Phenoxyacetic acid derivatives and their use as herbicides  
Phenoxyacetic acid derivatives of the formula: wherein R1, R2, Xn and A are as defined herein, and a process for preparing the derivatives. The derivatives are used as herbicides.
6310237 Process for the preparation and uses of derivatives of esters of α-methylene-β-hydroxy acids  
A process for the preparation of derivatives of halo-but-2-enoic acids and esters high in 2-ene content, several of which are novel. The esters and their derivatives are useful as promoters for...
6258296 Fluorine-substituted compounds and ferrielectric liquid-crystal composition containing the same  
A fluorine-substituted compound of the following general formula (1) or (2), and a ferrielectric liquid crystal composition comprising the above compound and a specific ferrielectric liquid...
6239317 Process for the production of halogeno-o-hydroxydiphenyl compounds  
There is described a four step process for the production of halogeno-o-hydroxydiphenyl compounds having the formula ##STR1##in which X is --O--or --CH2 --; m is 1 to 3; and n is 1 or 2;wherein in...
6177154 Alkoxybenzene derivative, liquid-crystal composition, and liquid-crystal display element  
Disclosed are (a) liquid crystalline compounds which are essential as component of the liquid crystal compositions, are excellent in miscibility with other liquid crystal compositions,...
6174573 Tolan compound and liquid crystal composition containing the same  
A novel tolan compound of the formula (I): ##STR1##wherein A is C1-10 alkyl, C1-10 alkoxy, cyclohexyl substituted by C1-10 alkyl at 4 position, cyclohexyl substituted by C1-10 alkoxy group at 4...
6153787 Intermediates for making heterocycles useful as COX-2 inhibitors  
The invention encompasses a process for making compounds of Formula I or Ia useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1##
6133469 Anti-ferroelectric liquid crystal compound  
A novel anti-ferroelectric liquid crystal compounds of the formula (1), ##STR1## wherein R is a linear alkyl group having 6 to 12 carbon atoms, X is a hydrogen atom or a fluorine atom, m is an...
6096783 Cyclobutane prostaglandin analogues as ocular hypotensive agents  
Cyclobutane analogs of PGF2α, PGD2, and PGE2 and methods of their use in treating glaucoma and ocular hypertension are disclosed.
6057006 Fluorocyclohexane derivatives, and liquid-crystalline medium  
The invention relates to fluorocyclohexane derivatives of the formula I ##STR1## in which R1, Z1, Z2, L1, L2, L3 and X are as defined as below: X is alkyl or alkoxy having 1 to 10 carbon atoms...
5985920 Difluoroprostaglandin derivatives and their use  
A fluorine-containing prostaglandin derivative of the formula (1) (or a salt thereof) and a medicine containing it, particularly, a preventive or therapeutic medicine for an eye disease: ##STR1##...
5728864 Liquid crystal compound having ferrielectric phase and liquid crystal composition  
A liquid crystal compound of the formula (1) ##STR1## wherein R is a linear alkyl group having 6 to 12 carbon atoms, both X and Y are hydrogen atoms or one of X and Y is a fluorine atom and the...
5728323 Process for preparing dialkyl tetrahalophthalates  
A process for the preparation of dialkyl tetrahalophthalates. A tetrahalophthalic anhydride or acid is dissolved in excess C1 -C18 alkanols. Residual sulfuric acid is removed by treatment with...
5686633 Inks, particularly for ink jet printing  
Inks, particularly inks for ink jet printing, contain at least one compound of the formula I ##STR1## as a stabilizer. The symbols R1, R2, R3, R4, R3 ' and R4 ' are as defined in claim 1. The...
5675032 Process for the preparation of specific polyethylene glycol di (2-(4-chloro-2-methylphenoxy)-propionic acid ester mixtures  
The present invention relates to an-economically and ecologically advantageous process, which is easy to carry out, for the preparation of specific polyethylene glycol diesters of...
5639906 Fluorescent and NMR sensitive pH indicators  
This invention relates to compositions and methods useful for measuring pH generally, and intracellular pH specifically, and, more particularly, to a new class of fluorescent and fluorinated (NMR...
5530145 Anticholesteremic compounds  
Novel anticholesteremic compounds capable of reducing blood cholesterol levels. Also included in this invention are (i) intermediates from which the abovementioned anticholesteremic compounds can...
5476965 Enzymatic resolution of substituted 2-methyl-propionic acid  
Provided are enzymatic methods for the selective hydrolytic resolution of certain enantiomers of a pharmaceutical compound, the pharmaceutical compound comprising a (±) mixture of a α-substituted...
5451573 Substituted cyclohexane derivatives for the treatment of diseases  
Substituted cyclohexane derivatives for the treatment of diseases Esters of cyclohexane derivatives of the formula I ##STR1## in which A--B, R3, R4, R5, Y and Z have the meanings indicated, for...
5387718 Method of manufacturing alkylphenyl alkyl ethers or alkylphenyl alkyl thioethers  
Alkylphenyl alkyl ethers or alkylphenyl alkyl thioethers, of the formula ##STR1## where U represents O or S; and R1 -R6 each independently represent an alkyl or aryl group with 1-6 C atoms, but R1...
5364560 Liquid crystal compound and liquid crystal display device  
An antiferroelectric liquid crystal compound which is a compound represented by ##STR1## wherein R denotes a linear aliphatic alkyl group having 6 to 14 carbon atoms; A denotes a single bond or an...
RE34726 Ferroelectric liquid crystal compositions containing chiral haloalkoxy tail units  
The subject application discloses a chiral nonracemic composition of the general formula: R1 --Ar--O--CH2 --C*HX--C*HY--CH2 --O--R2wherein R1 is an achiral tail of two to sixteen carbons; Ar is an...
5344638 Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract  
Disclosed are contrast agents of the formula ##STR1## contained in aqueous compositions and methods for their use in diagnostic radiology of the gastrointestinal tract whereinwherein Z=H, halo, C1...
5340498 Anti-ferroelectric liquid crystal and liquid crystal display device  
A novel anti-ferroelectric liquid crystal of the formula (I), ##STR1## wherein: is an integer of 3 to 8, each of X and Y is independently a hydrogen atom or a fluorine atom, Z is --CF3, --CH3 or...
5310757 3,3,5-trimethylcyclohexyl 2-methylpropionate derivatives, their method of preparation and therapeutic compositions in which they are present  
Derivatives of 3,3,5-trimethylcyclohexanol methyl-2-propionate, preparation method, and therapeutical compositions containing them. Such derivatives have general formula (I). ##STR1##
5294724 4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters and a process for their preparation  
4-Hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, process for their preparation, their use as pharmaceuticals, and pharmaceutical...
5290812 Phenoxyalkylcarboxylic acid derivatives and process of preparing the same  
Phenoxyalkylcarboxylic acid derivatives represented by the following formula (I) ##STR1## having a strong and selective leukotriene antagonistic action and useful for prophylaxis and therapy of...
5284971 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents  
Compounds of general formula (I) ##STR1## wherein R1 is (CH2)n ((CHNR7 R8)m C(O)R9 ; n=1-3; and m=0 or 1; R3 and R5 are independently Cl, Br, I, or CH3 ; R7 and R8 are independently H or (C1...
5264152 Optically active compound, liquid crystal composition and liquid crystal device comprising same  
An optically active compound represented by the formula (I): ##STR1## wherein R is a straight or branched chain alkyl or alkoxy group having 1 to 15 carbon atoms, ##STR2## is a 1,4-cyclohexylene...

Matches 1 - 50 out of 337 1 2 3 4 5 6 7 >